紐交所重啟三大中資電訊股ADR除牌程序
三大中資電訊股美國預託證券(ADR)未來命運再生變數,紐約證券交易所周二(5日)宣布「不再進行除牌」後翌日,當地時間周三(6日)即宣布要求三家公司ADR在美國除牌,當地時間下周一(11日)起生效。美國財長努欽早前向紐交所總裁Stacey Cunningham表示,不同意該所先前取消三家公司ADR在美國除牌的決定。
紐交所公告稱,是次決定建基於昨日(5日)美國財政部海外資產管制辦公室向其提供的新特定指引;並指發行人有權就決定申請覆核。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.